Perspectives on medication adherence and atypical antipsychotic medications

Psychiatric Services

Volumn 54, Issue 5, 2003, Pages 665-667

  Velligan, Dawn I ^a   Lam, Francis ^a,b   Ereshefsky, Larry ^a,b   Miller, Alexander L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ADULT; DAILY LIFE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; OUTPATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; REVIEW; SCHIZOPHRENIA; ARTICLE; PSYCHOLOGICAL ASPECT; PSYCHOPHARMACOLOGY; UNITED STATES;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; TEXAS;

EID: 0038203385     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.54.5.665     Document Type: Review

References (5)

1. Meltzer HY, McGurk SR: The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin 25:233-255, 1999
2. Dolder CR, Lacro JP, Dunn LB, et al: Antipsychotic medication adherence: is there a difference between typical and atypical agents? American Journal of Psychiatry 159:103-108, 2002
3. Docherty JP, Grogg AL, Kozma C, et al: Antipsychotic maintenance in schizophrenia: partial compliance and clinical outcome. Poster presented at the annual meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 7 to December 11, 2002
4. Velligan DI, Bow-Thomas CC, Huntzinger CD, et al: A randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia. American Journal of Psychiatry 157:1317-1323, 2000
5. Velligan DI, Prihoda TJ, Maples N, et al: A randomized single-blind pilot study of compensatory strategies in schizophrenia outpatients. Schizophrenia Bulletin 28:283-292, 2002